NEW YORK (GenomeWeb) – Sialix said this week that it has raised an additional $2 million as part of its Series B round, bringing the total raised to $6 million.
Biognosys this week named Patrick Plewman as its new CEO, taking over from Oliver Rinner, who is now the company's chief scientific officer.
Alex Bateman is joining the European Bioinformatics Institute as head of protein sequence resources, replacing Rolf Apweiler.
Sialix this week appointed Norrie Russell president and CEO – a newly established full-time position at the company.
The company, which has licensed intellectual property related to use of the auto-antibodies from UCSD, aims to develop the diagnostics first as CLIA-based tests and ultimately in a microarray format available to physicians.
The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.
The Associated Press reports that gene-edited food may soon be for sale.
The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.
In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.